| Date | Detail |
|---|---|
| Feb. 15, 2023 |
The SVB Securities Global Biopharma Conference
|
| Feb. 08, 2023 |
The Guggenheim Oncology Conference 2023
|
| Jan 9, 2023 |
J.P. Morgan 41st Annual Healthcare Conference 2023
|
| Dec. 13, 2022 |
BeiGene ASH 2022 ALPINE Late-Breaker Data Presentation
|
| Dec 11, 2022 |
BeiGene ASH 2022 Data Presentation
|
| Nov 16, 2022 |
The 13th Annual Jefferies Global Healthcare Conference
|
| Nov 11, 2022 |
Cowen 6th Annual IO Next Summit
|
| Sep 14, 2022 |
Morgan Stanley 20th Annual Global Healthcare Conference Webcast
|
| Jun 14, 2022 |
Goldman Sachs 43rd Annual Global Healthcare Conference
|
| Mar 07, 2022 |
Cowen 42nd Annual Health Care Virtual Conference
|
| Feb 10, 2022 |
Guggenheim Healthcare Talks - 2022 Oncology Conference
|
| Jan 11, 2022 |
BeiGene at the J.P. Morgan 40th Annual Healthcare Conference
|
| Aug 25, 2021 |
BeiGene Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipeline and Research
|
| Jun 11, 2021 |
BeiGene Investor Conference Call and Webcast to Discuss the Company’s ALPINE study, EHA 2021 Presentations, and Update on Brukinsa Development
|
| Jan 14, 2021 |
BeiGene at the J.P. Morgan 39th Annual Healthcare Conference
|
| Dec 28, 2020 |
BeiGene 2020 China National Reimbursement Drug List (NRDL) Results Conference Call
|
| Nov 23 - Dec 03, 2020 |
BeiGene at the Piper Sandler 32nd Annual Virtual Healthcare Conference
|
| Sep 17, 2020 |
BeiGene at the Morgan Stanley 18th Annual Global Healthcare Conference
|
| Jul 09, 2020 |
BeiGene Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipeline and Research
|
| Jun 10, 2020 |
BeiGene at Goldman Sachs 41st Annual Global Healthcare Conference
|
